Estrogens, inflammation and obesity: An overview

Frontiers in Biology

Volumn 7, Issue 1, 2012, Pages 40-47

  Miller, Colette N ^a   Brown, Lynda M ^b   Rayalam, Srujana ^c   Della Fera, Mary Anne ^c   Baile, Clifton A ^a,c  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

estrogen; high fat diets; inflammation; obesity; phytoestrogens; sex differences

Indexed keywords

ANIMALIA;

EID: 84855540056     PISSN: 16747984     EISSN: 16747992     Source Type: Journal    
DOI: 10.1007/s11515-011-1174-y     Document Type: Review

References (69)

1. Anand B K, Brobeck J R (1951). Hypothalamic control of food intake in rats and cats. Yale J Biol Med, 24(2): 123-140.
2. Basterfield L, Lumley L K, Mathers J C (2009). Wheel running in female C57BL/6J mice: impact of oestrus and dietary fat and effects on sleep and body mass. Int J Obes (Lond), 33(2): 212-218.
3. Berthoud H R, Morrison C (2008). The brain, appetite, and obesity. Annu Rev Psychol, 59(1): 55-92.
4. Boghossian S, Lemmon K, Park M, York D A (2009). High-fat diets induce a rapid loss of the insulin anorectic response in the amygdala. Am J Physiol Regul Integr Comp Physiol, 297(5): R1302-R1311.
5. Bryzgalova G, Lundholm L, Portwood N, Gustafsson J A, Khan A, Efendic S, Dahlman-Wright K (2008). Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat dietfed mice. Am J Physiol Endocrinol Metab, 295(4): E904-E912.
6. Chadwick C C, Chippari S, Matelan E, Borges-Marcucci L, Eckert A M, Keith J C Jr, Albert L M, Leathurby Y, Harris H A, Bhat R A, Ashwell M, Trybulski E, Winneker R C, Adelman S J, Steffan R J, Harnish D C (2005). Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity. Proc Natl Acad Sci USA, 102(7): 2543-2548.
7. Charradi K, Sebai H, Elkahoui S, Ben Hassine F, Limam F, Aouani E (2011). Grape seed extract alleviates high-fat diet-induced obesity and heart dysfunction by preventing cardiac siderosis. Cardiovasc Toxicol, 11(1): 28-37.
8. Clegg D J, Brown L M, Woods S C, Benoit S C (2006). Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes, 55(4): 978-987.
9. Clegg D J, Gotoh K, Kemp C, Wortman M D, Benoit S C, Brown L M, D'Alessio D, Tso P, Seeley R J, Woods S C (2011). Consumption of a high-fat diet induces central insulin resistance independent of adiposity. Physiol Behav, 103(1): 10-16.
10. Clegg D J, S C Woods (2004). The physiology of obesity. Clin Obstet Gynecol, 47(4): 967-979; discussion 980-961.
11. Couse J F, Lindzey J, Grandien K, Gustafsson J A, Korach K S (1997). Tissue distribution and quantitative analysis of estrogen receptoralpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology, 138(11): 4613-4621.
12. Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, Szabo G (2011). Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology, 54(1): 133-144.
13. Davis J E, Gabler N K, Walker-Daniels J, Spurlock M E (2008). Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity (Silver Spring), 16(6): 1248-1255.
14. De Souza C T, Araujo E P, Bordin S, Ashimine R, Zollner R L, Boschero A C, Saad M J, Velloso L A (2005). Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology, 146(10): 4192-4199.
15. Enriori P J, Evans A E, Sinnayah P, Cowley M A (2006). Leptin resistance and obesity. Obesity (Silver Spring), 14(Suppl 5): 254S-258S.
16. Evans M J, Eckert A, Lai K, Adelman S J, Harnish D C (2001). Reciprocal antagonism between estrogen receptor and NF-kappaB activity in vivo. Circ Res, 89(9): 823-830.
17. Fazeli M, Zarkesh-Esfahani S H, et al(2004). Effects of Estrogen on Leptin Signaling and Leptin-induced TNF-alpha Production. British Endocrine Societies, Brighton, UK, BioScientifica.
18. Ghisletti S, Meda C, Maggi A, Vegeto E (2005). 17beta-estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization. Mol Cell Biol, 25(8): 2957-2968.
19. Gong L, Yao F, Hockman K, Heng H H, Morton G J, Takeda K, Akira S, Low M J, Rubinstein M, MacKenzie R G (2008). Signal transducer and activator of transcription-3 is required in hypothalamic agoutirelated protein/neuropeptide Y neurons for normal energy homeostasis. Endocrinology, 149(7): 3346-3354.
20. Gonzales A M, Orlando R A (2008). Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutr Metab (Lond), 5(1): 17.
21. Hamilton K L, Lin L, Wang Y, Knowlton A A (2007). Effect of ovariectomy on cardiac gene expression: inflammation and changes in SOCS gene expression. Physiol Genomics, 32(2): 254-263.
22. Harris H A, Albert L M, Leathurby Y, Malamas M S, Mewshaw R E, Miller C P, Kharode Y P, Marzolf J, Komm B S, Winneker R C, Frail D E, Henderson R A, Zhu Y, Keith J C Jr (2003). Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology, 144(10): 4241-4249.
23. Haslam D W, James W P (2005). Obesity. Lancet, 366(9492): 1197-1209.
24. Hetherington R, Ranson S (1940). Hypothalamic lesions and adiposity in the rat. Anat Rec, 78(2): 149-172.
25. Hewitt K N, Pratis K, Jones M E, Simpson E R (2003). Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology, 145(4): 1842-1848.
26. Hong J, Stubbins R E, Smith R R, Harvey A E, Núñez N P (2009). Differential susceptibility to obesity between male, female and ovariectomized female mice. Nutr J, 8(1): 11.
27. Hotamisligil G S (2006). Inflammation and metabolic disorders. Nature, 444(7121): 860-867.
28. Jayaprakasam B, Olson L K, Schutzki R E, Tai M H, Nair M G (2006). Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in Cornelian cherry (Cornus mas). J Agric Food Chem, 54(1): 243-248.
29. Kahn B B, Flier J S (2000). Obesity and insulin resistance. J Clin Invest, 106(4): 473-481.
30. Kalaitzidis D, Gilmore T D (2005). Transcription factor cross-talk: the estrogen receptor and NF-kappaB. Trends Endocrinol Metab, 16(2): 46-52.
31. Kaneko M, Niinuma Y, Nomura Y (2003). Activation signal of nuclear factor-kappa B in response to endoplasmic reticulum stress is transduced via IRE1 and tumor necrosis factor receptor-associated factor 2. Biol Pharm Bull, 26(7): 931-935.
32. Kennedy A, Martinez K, Chuang C C, LaPoint K, McIntosh M (2008). Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications. J Nutr, 139(1): 1-4.
33. Kim S, Jin Y, Choi Y, Park T (2011). Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. Biochem Pharmacol, 81(11): 1343-1351.
34. Kleinridders A, Schenten D, Könner A C, Belgardt B F, Mauer J, Okamura T, Wunderlich F T, Medzhitov R, Brüning J C (2009). MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab, 10(4): 249-259.
35. Kuiper G G, Lemmen J G, Carlsson B, Corton J C, Safe S H, van der Saag P T, van der Burg B, Gustafsson J A (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 139(10): 4252-4263.
36. Lehrke M, Lazar M A (2004). Inflamed about obesity. Nat Med, 10(2): 126-127.
37. Milanski M, Degasperi G, Coope A, Morari J, Denis R, Cintra D E, Tsukumo D M, Anhe G, Amaral M E, Takahashi H K, Curi R, Oliveira H C, Carvalheira J B, Bordin S, Saad M J, Velloso L A (2009). Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci, 29(2): 359-370.
38. Morgan K, Obici S, Rossetti L (2004). Hypothalamic responses to longchain fatty acids are nutritionally regulated. J Biol Chem, 279(30): 31139-31148.
39. Oh-I S, Thaler J P, Ogimoto K, Wisse B E, Morton G J, Schwartz M W (2010). Central administration of interleukin-4 exacerbates hypothalamic inflammation and weight gain during high-fat feeding. Am J Physiol Endocrinol Metab, 299(1): E47-E53.
40. Park H J, Della-Fera M A, Hausman D B, Rayalam S, Ambati S, Baile C A (2009). Genistein inhibits differentiation of primary human adipocytes. J Nutr Biochem, 20(2): 140-148.
41. Park Y J, Jang YM, Kwon Y H (2009). Isoflavones prevent endoplasmic reticulum stress-mediated neuronal degeneration by inhibiting tau hyperphosphorylation in SH-SY5Y cells. J Med Food, 12(3): 528-535.
42. Poggi M, Engel D, et al (2011). "CD40L Deficiency Ameliorates Adipose Tissue Inflammation and Metabolic Manifestations of Obesity in Mice." Arterioscler Thromb Vasc Biol.
43. Posey K A, Clegg D J, Printz R L, Byun J, Morton G J, Vivekanandan-Giri A, Pennathur S, Baskin D G, Heinecke J W, Woods S C, Schwartz M W, Niswender K D (2009). Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am J Physiol Endocrinol Metab, 296(5): E1003-E1012.
44. Priego T, Sánchez J, Picó C, Palou A (2009). Sex-associated differences in the leptin and ghrelin systems related with the induction of hyperphagia under high-fat diet exposure in rats. Horm Behav, 55(1): 33-40.
45. Reaven G M (1995). Pathophysiology of insulin resistance in human disease. Physiol Rev, 75(3): 473-486.
46. Rocha M, Bing C, Williams G, Puerta M (2004). Physiologic estradiol levels enhance hypothalamic expression of the long form of the leptin receptor in intact rats. J Nutr Biochem, 15(6): 328-334.
47. Rui L, Yuan M, Frantz D, Shoelson S, White M F (2002). SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem, 277(44): 42394-42398.
48. Schwartz MW, Sipols A J, Marks J L, Sanacora G, White J D, Scheurink A, Kahn S E, Baskin D G, Woods S C, Figlewicz D P, et al (1992). Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology, 130(6): 3608-3616.
49. Shi H, Clegg D J (2009). Sex differences in the regulation of body weight. Physiol Behav, 97(2): 199-204.
50. Stein B, Yang M X (1995). Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol, 15(9): 4971-4979.
51. Stice J P, Knowlton A A (2008). Estrogen, NFkappaB, and the heat shock response. Mol Med, 14(7-8): 17-27.
52. Straub R H (2007). The complex role of estrogens in inflammation. Endocr Rev, 28(5): 521-574.
53. Suganami T, Nishida J, Ogawa Y (2005). A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol, 25(10): 2062-2068.
54. Tsukumo D M, Carvalho-Filho M A, Carvalheira J B, Prada P O, Hirabara S M, Schenka A A, Araújo E P, Vassallo J, Curi R, Velloso L A, Saad MJ (2007). Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes, 56(8): 1986-1998.
55. Ueki K, Kondo T, Kahn C R (2004). Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol, 24(12): 5434-5446.
56. Vegeto E, Belcredito S, Etteri S, Ghisletti S, Brusadelli A, Meda C, Krust A, Dupont S, Ciana P, Chambon P, Maggi A (2003). Estrogen receptor-mediates the brain antiinflammatory activity of estradiol. Proc Natl Acad Sci USA, 100(16): 9614-9619.
57. Vegeto E, Belcredito S, Ghisletti S, Meda C, Etteri S, Maggi A (2006). The endogenous estrogen status regulates microglia reactivity in animal models of neuroinflammation. Endocrinology, 147(5): 2263-2272.
58. Vegeto E, Bonincontro C, Pollio G, Sala A, Viappiani S, Nardi F, Brusadelli A, Viviani B, Ciana P, Maggi A (2001). Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci, 21(6): 1809-1818.
59. Vinchon M, Weill J, Delestret I, Dhellemmes P (2009). Craniopharyngioma and hypothalamic obesity in children. Childs Nerv Syst, 25(3): 347-352.
60. Wang J, Obici S, Morgan K, Barzilai N, Feng Z, Rossetti L (2001). Overfeeding rapidly induces leptin and insulin resistance. Diabetes, 50(12): 2786-2791.
61. Wang Y, Beydoun M A, Liang L, Caballero B, Kumanyika S K (2008). Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring), 16(10): 2323-2330.
62. Wauman J, Tavernier J (2011). Leptin receptor signaling: pathways to leptin resistance. Front Biosci, 17: 2771-2793.
63. Weisberg S P, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel R L, Ferrante A W Jr (2006). CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest, 116(1): 115-124.
64. Wellen K E, Hotamisligil G S (2003). Obesity-induced inflammatory changes in adipose tissue. J Clin Invest, 112(12): 1785-1788.
65. Wellen K E, Hotamisligil G S (2005). Inflammation, stress, and diabetes. J Clin Invest, 115(5): 1111-1119.
66. Yang L, Hotamisligil G S (2008). Stressing the brain, fattening the body. Cell, 135(1): 20-22.
67. York D, Hansen B (1998). Animal Models of Obesity. Handbook of Obesity. G. Bray, C. Bouchard and W. James. New York, Marcel Dekker, Inc.
68. Yu H P, Hsu J C, Hwang T L, Yen C H, Lau Y T (2008). Resveratrol attenuates hepatic injury after trauma-hemorrhage via estrogen receptor-related pathway. Shock, 30(3): 324-328.
69. Zhang X, Zhang G, Zhang H, Karin M, Bai H, Cai D (2008). Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell, 135(1): 61-73.